Blueprint Medicines Corp.
NASDAQ: BPMC
$44.07
-$1.78 (-3.9%)
Closing price February 8, 2023
Tuesday’s top analyst upgrades and downgrades included Boeing, Boston Scientific, ChargePoint, Deere, Foot Locker, Horizon Therapeutics, Nu, Ross Stores, Salesforce, United Parcel Service, VF,...
5 months ago
Last Updated: 5 months ago
Wells Fargo issues a few calls and warns investors that these stocks could underperform the markets, even considering the bear market we are in now.
7 months ago
Monday's top analyst upgrades and downgrades included Docusign, Electronic Arts, Enterprise Products Partners, GoodRx, Netflix, Spirit Airlines, Take-Two Interactive Software, Target, Tesla and...
7 months ago
Last Updated: 7 months ago
Wednesday’s additional top analyst upgrades and downgrades were on Danaher, eBay, GoodRx, Infosys, Valero Energy, Xylem and more.
8 months ago
Thursday afternoon's top analyst upgrades and downgrades included Autodesk, Check Point Software, DoorDash, Hilton, Nvidia, Upstart and more.
11 months ago
Last Updated: 11 months ago
Wednesday's top analyst upgrades and downgrades included Apple, Applied Materials, BP, Bumble, Carrier, Harley-Davidson, Hess, Illumina, Johnson Controls and Lennar.
1 year ago
Last Updated: 1 year ago
Monday's top analyst upgrades and downgrades included AbbVie, Alibaba, Archer Daniels Midland, Best Buy, Intel, Nikola, Peloton Interactive, SAP, Under Armour and Wynn Resorts.
2 years ago
Last Updated: 1 year ago
Blueprint Medicines announced early on Tuesday that it had entered into a global collaboration with pharmaceutical giant Roche in which it may receive up to $1.7 billion.
2 years ago
Tuesday's top analyst calls included Advanced Micro Devices, Alcoa, Biomarin Pharmaceutical, Coca-Cola, Ford, General Motors, Intel, Kinder Morgan, Micron Technology, Nvidia, Tesla, Twitter and...
2 years ago
Last Updated: 2 years ago